Abstract: The present invention is targeted at a composition, in particular a cosmetic and non-therapeutic composition, for the care, the hygiene and/or the cleansing of keratin materials, comprising at least (i) all or part of a lysate, isolated or not, from a medium for the fermentation of a non-pathogenic and aerobic proteobacterium or a (glyco)oligopeptide fraction isolated from such a lysate, (ii) at least one mucopolysaccharide, in particular with a weight of greater than 10 kD, and (iii) at least one moisturizing agent distinct from (i) and from (ii), preferably in aqueous formulation and in the presence of electrolytes. It is additionally targeted at a method for care, hygiene and/or cleansing of a keratin material, comprising the use of such a composition.

Abstract: Assembly for cleaning the skin and/or keratin fibers, comprising: ?—a body (2) intended to contain a cleaning composition (S) for the skin and/or keratin fibers, comprising at least one wall (3) delimiting a volume forming a reservoir (4) for housing the cleaning composition (S), at least one supply orifice (5) to allow the cleaning composition (S) to exit from said body (2), ?—at least one valve (6) making it possible to close or not close said at least one supply orifice (5), ?—at least one pad (10, 10a, 10b) intended to be in contact with the skin and/or the keratin fibers, capable of being removably fixed to the body (2).

Abstract: The present invention relates to an extract of bacterium of Sphingomonas genus, compositions comprising at least one bacterium of Sphingomonas genus or said extract, the uses thereof, as well as their implementations in cosmetic methods.

Abstract: A regime or regimen for artificially coloring the skin entails topically applying thereon at least a) dehydroascorbic acid and/or a monomeric derivative thereof of formula (I) below and/or an isomeric form thereof of formula (I?) below and/or a polymeric derivative thereof: in which: OR1 and OR2, which may be identical or different, are each OH; a saturated or unsaturated, linear or branched C1-C30 and more preferentially C1-C18 alkoxy radical; a glycoside and more preferentially glucose; an ester of a saturated or unsaturated, linear or branched C1-C30 (preferably C1-C18) aliphatic carboxylic acid, which may be substituted with an aryl radical or a heterocycle; an aryl or heterocyclic carboxylic acid ester, which may be substituted with at least one saturated or unsaturated, linear or branched C1-C30 (more preferentially C1-C18) alkyl radical; a phosphate group; a sulfate group, and b) at least one amine compound.

Abstract: Dehydroascorbic acid and polymeric/monomeric derivatives and isomers thereof are useful for artificially coloring the skin and more particularly as a skin self-tanning agent; the dehydroascorbic acid may be formed “in situ” from ascorbic acid or a derivative or salt thereof via chemical oxidation and/or via enzymatic oxidation, and a two-component agent thereof includes a) a first component (B) containing, in a physiologically acceptable medium, at least ascorbic acid or a derivative or salt thereof; b) a second component (C) containing, in a physiologically acceptable medium, at least one chemical oxidizing agent and/or one enzymatic oxidizing agent; components (B) and (C) being stored separately.

Abstract: Expression of a messenger RNA which encodes a protein which is expressed by differentiated cells, notably the cells of the skin or appendages thereof, is inhibited by topically administering to said differentiated cells a thus effective amount of at least one double-stranded RNA oligonucleotide, formulated into a topically applicable, physiologically acceptable medium therefor; such regime or regimen is useful for treating a variety of afflictions or conditions, e.g., combating the signs of skin aging, stimulating hair growth or retarding loss thereof, inhibiting cellular proliferation and/or differentiation, etc.

Abstract: A substrate is filled with a reagent that presents a stable free radical character, and that is capable of producing a visible reaction in the presence of at least one free radical scavenger analyte of the skin.

Abstract: A regime or regimen for artificially coloring the skin entails topically applying thereon at least a) dehydroascorbic acid and/or a monomeric derivative thereof of formula (I) below and/or an isomeric form thereof of formula (I?) below and/or a polymeric derivative thereof: in which: OR1 and OR2, which may be identical or different, are each OH; a saturated or unsaturated, linear or branched C1-C30 and more preferentially C1-C18 alkoxy radical; a glycoside and more preferentially glucose; an ester of a saturated or unsaturated, linear or branched C1-C30 (preferably C1-C18) aliphatic carboxylic acid, which may be substituted with an aryl radical or a heterocycle; an aryl or heterocyclic carboxylic acid ester, which may be substituted with at least one saturated or unsaturated, linear or branched C1-C30 (more preferentially C1-C18) alkyl radical; a phosphate group; a sulfate group, and b) at least one amine compound.

Abstract: Cosmetic compositions for artificially coloring the skin contain, formulated into a physiologically acceptable medium, a) at least dehydroascorbic acid and/or a monomeric derivative and/or isomeric form and/or polymeric derivative thereof, and b) at least one preferably monocarbonyl or polycarbonyl self-tanning agent; the dehydroascorbic acid may be formed “in situ” from ascorbic acid or a derivative thereof or a salt thereof via chemical oxidation and/or via enzymatic oxidation.

Abstract: Processes for coloring a keratin material, comprising applying to the keratin material, in the presence of oxygen, at least one component (A) comprising, in a physiologically acceptable medium:—at least one dye precursor chosen from compounds comprising at least one aromatic ring comprising at least two hydroxyl groups borne by two successive carbon atoms of the at least one aromatic ring, and at least one catalytic system comprising at least one first catalyst (1) chosen from Mn(II) and Zn(II) salts and oxides and/or at least one second catalyst (2) chosen from alkali metal hydrogen carbonates and alkaline-earth metal hydrogen carbonates followed by applying at least one component (B) comprising at least one acidic composition to fix the shade and followed by applying at least one component (C) comprising at least one alkaline composition to increase the intensity of the color or to modify the shade and optionally fixing the new color or shade obtained by applying a new application of at least one compositio

Abstract: A composition for coloring a keratin material, comprising: (i) at least one coloring agent component comprising, in a physiologically acceptable medium, at least one dye precursor chosen from compounds comprising at least one aromatic ring comprising at least two hydroxyl groups borne by two successive carbon atoms of the at least one aromatic ring, and at least one catalytic system comprising at least one first catalyst (1) chosen from Mn(II) and Zn(II) salts and oxides and at least one second catalyst (2) chosen from alkali metal hydrogen carbonates and alkaline-earth metal hydrogen carbonates; wherein the catalysts (1) and (2) are present with the at least one dye precursor in a single composition (A) or separated into two components (A1) and (A2) wherein the at least one dye precursor is present in at least one of the components (A1) and (A2); and at least one component chosen from: (ii) a component (B) comprising at least one acidic composition, and (iii) a component (C) comprising at least one

Abstract: Disclosed methods and systems related to enabling an analysis using a three-dimensional facial image. One of the methods involves facilitating construction of a three-dimensional facial image using at least captured image of a subject's face. The method also involves facilitating a simulation of use of an aesthetic feature on the three-dimensional facial image and/or processing of the three-dimensional facial image to enable a beauty analysis.

Abstract: Expression of a messenger RNA which encodes a protein which is expressed by differentiated cells, notably the cells of the skin or appendages thereof, is inhibited by topically administering to said differentiated cells a thus effective amount of at least one double-stranded RNA oligonucleotide, formulated into a topically applicable, physiologically acceptable medium therefor; such regime or regimen is useful for treating a variety of afflictions or conditions, e.g., combating the signs of skin aging, stimulating hair growth or retarding loss thereof, inhibiting cellular proliferation and/or differentiation, etc.

Abstract: The invention relates to the use of at least one agent for screening out light radiation with a wavelength ranging from 370 to 500 nm as an agent for inhibiting the degradation of endogenous carotenoids present in the skin. The invention is useful for treating skin disorders caused by sunlight (e.g., solar urticaria, actinic dermatitis and pigmentation marks). The invention also relates to novel aminoaryl-vinyl-s-triazine compounds and to the use thereof as agents for screening out light radiation ranging from 370 to 500 nm.

Abstract: The present invention relates to a composition for artificially colouring the skin, comprising, in a physiologically acceptable medium: a) at least one self-tanning agent, and b) at least one dye that can be obtained by reacting dehydroascorbic acid and/or a monomeric derivative thereof of formula (I) and/or an isomer thereof of formula (I?) and/or a polymeric derivative thereof, especially dimers of formula (II), with an amine compound. The present invention also relates to a process for artificially colouring the skin, comprising the application of a composition comprising, in a physiologically acceptable medium: a) at least one self-tanning agent, and b) at least one dye that can be obtained by reacting dehydroascorbic acid and/or a monomeric derivative thereof of formula (I) and/or an isomer thereof of formula (I?) and/or a polymeric derivative thereof, especially dimers of formula (II), with an amine compound.

Abstract: Dehydroascorbic acid and polymeric/monomeric derivatives and isomers thereof are useful for artificially coloring the skin and more particularly as a skin self-tanning agent; the dehydroascorbic acid may be formed “in situ” from ascorbic acid or a derivative or salt thereof via chemical oxidation and/or via enzymatic oxidation, and a two-component agent thereof includes a) a first component (B) containing, in a physiologically acceptable medium, at least ascorbic acid or a derivative or salt thereof; b) a second component (C) containing, in a physiologically acceptable medium, at least one chemical oxidizing agent and/or one enzymatic oxidizing agent; components (B) and (C) being stored separately.

Abstract: The present disclosure relates to a cosmetic process to reduce or eliminate the odor retained by keratinic materials placed in contact with water treated with a halogenated disinfectant, such as a chlorinated disinfectant and/or a brominated disinfectant, comprising applying onto the keratinic materials at least one composition comprising at least one aminoalkane sulphonic or sulphonothioic acid compound or a salt thereof or an amide derivative thereof in a cosmetically acceptable medium, then if necessary rinsing with water.

Abstract: A method of performing a beauty analysis is disclosed. The method comprises receiving information of at least one portion of a subject's external body condition, identifying in the information at least one condition, extracting from the information at least one feature of the at least one condition, and storing extracted information reflective of the at least one feature.

Abstract: Described is a method of reducing transcutaneous passage of an orthodiphenol oxidation dye by adding a catalytic system of Mn(II) or Zn(II) salt or oxide and at least one alkaline or alkaline earth hydrogenocarbonate to the orthodiphenol oxidation dye composition.

Abstract: A method, device and system for determining skin type. The method includes a step of applying at least one drop of substance onto a zone of the skin or on a collector member previously in contact with the zone of the skin. The substance can modify at least one physicochemical property of the surface of the zone or of the collector member exposed to the substance. After the drop has disappeared or been removed, the extent of the surface is evaluated and the skin type is determined as a function of this evaluation.